|
Jul 10
|
Ozempic, obesity drugs 'upending entire idea' of weight loss: Reporter
|
|
Jul 10
|
UPDATE 6-EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported
|
|
Jul 10
|
UPDATE 2-European stocks start week on steady footing, China worries linger
|
|
Jul 9
|
Ozempic isn’t alone. A whole class of ‘revolutionary’ weight-loss drugs is on the market—but only for the wealthy
|
|
Jul 7
|
TikTok's Entry Into Music Streaming Raises Concerns For Spotify, Novo Nordisk Accuses Pharmacies Over Illegal Sale Of Obesity Drugs, ChatGPT's Popularity Takes a Hit: Today's Top Stories
|
|
Jul 7
|
After Legal Action Against Wellness Clinics, Novo Nordisk Accuses Pharmacies Over Illegal Sale Of Semaglutide-Based Products
|
|
Jul 6
|
Novo Nordisk (NVO) Dips More Than Broader Markets: What You Should Know
|
|
Jul 6
|
Wegovy maker Novo Nordisk sues Florida pharmacies over copycat drugs
|
|
Jul 6
|
Novo Nordisk spent $11 million on Ozempic promotion
|
|
Jul 6
|
Ozempic Sales Are Soaring -- Here's Why They Could Go Even Higher
|
|
Jul 5
|
Can Eli Lilly's (LLY) Continue its Ride on Obesity Drug Wave?
|
|
May 4
|
FOCUS-Novo Nordisk rivals see room to compete in $100 bln weight-loss drug market
|
|
May 4
|
UPDATE 2-Novo Nordisk: U.S. is priority for weight-loss drug over new markets
|
|
May 4
|
Novo Nordisk cuts some US supply of obesity drug Wegovy to cope with demand
|
|
May 4
|
Novo Nordisk's sales increased by 27% in Danish kroner and by 25% at constant exchange rates to DKK 53.4 billion in the first three months of 2023
|
|
May 4
|
Weight-Loss Drugs Will Be Blockbusters. Here’s the Stock to Buy.
|
|
May 3
|
Drug, Biotech Stocks' Q1 Earnings on May 4: REGN, ZTS & More
|
|
May 3
|
Novo Nordisk A/S - share repurchase programme
|
|
May 3
|
2 Stocks That Could Triple Your Investment by 2030
|
|
May 3
|
Analysis-Investors see big Novo Nordisk stock boost if obesity drug shows heart benefit
|